NCT05383963 Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
| NCT ID | NCT05383963 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2022-07-15 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2022-07-15 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective observational study to develop a Machine Learning Algorithm to evaluate parameters collected from routine data for the diagnosis of sepsis and septic shock and their influence on time to diagnosis and patient outcome.
Eligibility Criteria
Inclusion Criteria: * age \>= 18 years * ICU stay of \> 24 hours Exclusion Criteria: * none
Contact & Investigator
Claudia Spies, MD, Prof.
STUDY DIRECTOR
Charite University, Berlin, Germany
Frequently Asked Questions
Who can join the NCT05383963 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05383963 currently recruiting?
Yes, NCT05383963 is actively recruiting participants. Contact the research team at claudia.spies@charite.de for enrollment information.
Where is the NCT05383963 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT05383963 clinical trial?
NCT05383963 is sponsored by Charite University, Berlin, Germany. The principal investigator is Claudia Spies, MD, Prof. at Charite University, Berlin, Germany. The trial plans to enroll 10,000 participants.